We are live on ! Find out more
RLMD icon

Relmada Therapeutics
RLMD

110 hedge funds and large institutions have $66.6M invested in Relmada Therapeutics in 2022 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 29 increasing their positions, 34 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

342% more call options, than puts

Call options by funds: $7.39M | Put options by funds: $1.67M

15% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 34

18% less funds holding

Funds holding: 134 → 110 (-24)

22.17% less ownership

Funds ownership: 85.77% → 63.6% (-22%)

39% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 57

93% less capital invested

Capital invested by funds: $954M → $66.6M (-$887M)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

Holders
110
Holders Change
-24
Holders Change %
-17.91%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
35
Increased
29
Reduced
34
Closed
57
Calls
$7.39M
Puts
$1.67M
Net Calls
+$5.72M
Net Calls Change
+$87.3M

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$20.9M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$9.66M
3
Millennium Management
Millennium Management
New York
+$9.15M
4
Two Sigma Investments
Two Sigma Investments
New York
+$4.17M
5
Walleye Capital
Walleye Capital
New York
+$4.16M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$88.2M
2
BI
BVF Inc
California
-$76.9M
3
RCM
RA Capital Management
Massachusetts
-$74M
4
VA
VR Adviser
New York
-$56.2M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$31M
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$501K +$1.26M +143,535 New
OQS
27
Occudo Quantitative Strategies
Florida
$456K +$1.15M +130,711 New
XT
28
XTX Topco
Cayman Islands
$452K +$1.14M +129,387 New
GCP
29
GSA Capital Partners
United Kingdom
$428K +$1.08M +122,590 New
Connor, Clark & Lunn Investment Management (CC&L)
30
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$414K +$740K +84,315 +246%
Jane Street
31
Jane Street
New York
$414K +$1.04M +118,583 New
SEI Investments
32
SEI Investments
Pennsylvania
$354K +$890K +101,345 New
TCM
33
Tang Capital Management
California
$349K -$2.63M -300,000 -75%
CS
34
Candriam SCA
Luxembourg
$322K -$724K -82,419 -47%
Fidelity Investments
35
Fidelity Investments
Massachusetts
$292K +$730K +83,151 +13,767%
AI
36
AdvisorShares Investments
Maryland
$284K +$623K +70,904 +678%
N
37
Nuveen
North Carolina
$280K -$52.3K -5,951 -7%
AW
38
Apricus Wealth
South Carolina
$270K -$263K -30,000 -28%
SSA
39
Schonfeld Strategic Advisors
New York
$263K -$660K -75,200 -50%
AC
40
Aristides Capital
Kentucky
$242K +$609K +69,322 New
IC
41
Ikarian Capital
Texas
$229K +$575K +65,491 New
CAC
42
Cowen and Company
New York
$223K -$1.34M -152,430 -70%
Charles Schwab
43
Charles Schwab
California
$214K -$80K -9,105 -13%
DTL
44
Dynamic Technology Lab
Singapore
$181K +$455K +51,775 New
EGM
45
Engineers Gate Manager
New York
$159K +$399K +45,424 New
Mariner
46
Mariner
Kansas
$143K +$361K +41,080 New
CSS
47
Cubist Systematic Strategies
Connecticut
$142K +$48.9K +5,565 +16%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$128K +$2.46K +280 +0.8%
Squarepoint
49
Squarepoint
New York
$123K +$310K +35,281 New
MHC
50
Meyer Handelman Company
New York
$114K – – –
1
2
3 4 5

RLMD Hedge Fund Activity: Q4 2022 in Review

110 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Relmada Therapeutics (RLMD) for Q4 2022, worth a combined $66.6M — down 93% from $954M a quarter earlier.

Sellers outnumbered buyers: 57 funds closed out of RLMD and 35 opened new positions — a net loss of 22 holders — while 34 trimmed existing stakes and 29 added.

The largest buyer was Deep Track Capital, adding an estimated $20.9M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $88.2M sold.

  • 110 institutional investors held Relmada Therapeutics (RLMD) as of Q4 2022, down from 134 in Q3 2022.
  • Funds reported $66.6M of Relmada Therapeutics stock for Q4 2022, down 93% quarter-over-quarter.
  • 35 funds opened new Relmada Therapeutics positions in Q4 2022 and 57 closed out, a net change of -22 holders.
  • The largest Relmada Therapeutics buyer in Q4 2022 was Deep Track Capital, an estimated $20.9M added.
  • The largest Relmada Therapeutics seller in Q4 2022 was Perceptive Advisors, an estimated $88.2M sold.

Based on aggregated 13F filings for Q4 2022.